Subsequent chemotherapy with paclitaxel plus cetuximab-based chemotherapy following immune checkpoint inhibitor in recurrent or metastatic squamous cell carcinoma of the head and neck. - Tanaka H; Enokida T; Okano S; Fujisawa T; Tanaka N; Takeshita N; Onaga R; Hoshi Y; Wada A; Sato M; Ueda Y; Tahara M (Frontiers in oncology, 2023)